CDC-Authored Genomics and Precision Health Publications Database
Last data update: Mar 02, 2021. (Total: 3583 publications since 2011)
| Query Trace: all>>Jennifer L Konopka-Anstadt[CDC Author] |
|---|
| Development of a new oral poliovirus vaccine for the eradication end game using codon deoptimization. Jennifer L Konopka-Anstadt, Ray Campagnoli, Annelet Vincent, Jing Shaw, Ling Wei, Nhien T Wynn, Shane E Smithee, Erika Bujaki, Ming Te Yeh, Majid Laassri, Tatiana Zagorodnyaya, Amy J Weiner, Konstantin Chumakov, Raul Andino, Andrew MacAdam, Olen Kew, and Cara C Burns NPJ vaccines 2020 Mar 5(1) 26 |
| Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials. Ilse De Coster, Isabel Leroux-Roels, Ananda S Bandyopadhyay, Christopher Gast, Kanchanamala Withanage, Katie Steenackers, Philippe De Smedt, Annelies Aerssens, Geert Leroux-Roels, M Steven Oberste, Jennifer L Konopka-Anstadt, William C Weldon, Alan Fix, John Konz, Rahnuma Wahid, John Modlin, Ralf Clemens, Sue Ann Costa Clemens, Novilia S Bachtiar, and Pierre Van Damme Lancet (London, England) 2020 Dec |
| Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials. Xavier Sáez-Llorens, Ananda S Bandyopadhyay, Christopher Gast, Tirza De Leon, Rodrigo DeAntonio, Jose Jimeno, Maria Isabel Caballero, Gabriela Aguirre, M Steven Oberste, William C Weldon, Jennifer L Konopka-Anstadt, John Modlin, Novilia S Bachtiar, Alan Fix, John Konz, Ralf Clemens, Sue Ann Costa Clemens, and Ricardo Rüttimann Lancet (London, England) 2020 Dec |
| Updated Characterization of Outbreak Response Strategies for 2019-2029: Impacts of Using a Novel Type 2 Oral Poliovirus Vaccine Strain. Dominika A Kalkowska, Mark A Pallansch, Amanda Wilkinson, Ananda S Bandyopadhyay, Jennifer L Konopka-Anstadt, Cara C Burns, M Steven Oberste, Steven G F Wassilak, Kamran Badizadegan, and Kimberly M Thompson Risk analysis : an official publication of the Society for Risk Analysis 2020 Nov |
| Development of a new oral poliovirus vaccine for the eradication end game using codon deoptimization. Jennifer L Konopka-Anstadt, Ray Campagnoli, Annelet Vincent, Jing Shaw, Ling Wei, Nhien T Wynn, Shane E Smithee, Erika Bujaki, Ming Te Yeh, Majid Laassri, Tatiana Zagorodnyaya, Amy J Weiner, Konstantin Chumakov, Raul Andino, Andrew MacAdam, Olen Kew, and Cara C Burns NPJ vaccines 2020 26 |
| Pan-viral serology implicates enteroviruses in acute flaccid myelitis. Ryan D Schubert, Isobel A Hawes, Prashanth S Ramachandran, Akshaya Ramesh, Emily D Crawford, John E Pak, Wesley Wu, Carly K Cheung, Brian D O'Donovan, Cristina M Tato, Amy Lyden, Michelle Tan, Rene Sit, Gavin A Sowa, Hannah A Sample, Kelsey C Zorn, Debarko Banerji, Lillian M Khan, Riley Bove, Stephen L Hauser, Amy A Gelfand, Bethany L Johnson-Kerner, Kendall Nash, Kalpathy S Krishnamoorthy, Tanuja Chitnis, Joy Z Ding, Hugh J McMillan, Charles Y Chiu, Benjamin Briggs, Carol A Glaser, Cynthia Yen, Victoria Chu, Debra A Wadford, Samuel R Dominguez, Terry Fei Fan Ng, Rachel L Marine, Adriana S Lopez, W Allan Nix, Ariane Soldatos, Mark P Gorman, Leslie Benson, Kevin Messacar, Jennifer L Konopka-Anstadt, M Steven Oberste, Joseph L DeRisi, and Michael R Wilson Nature medicine 2019 Oct |
| Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid Myelitis. Nischay Mishra, Terry Fei Fan Ng, Rachel L Marine, Komal Jain, James Ng, Riddhi Thakkar, Adrian Caciula, Adam Price, Joel A Garcia, Jane C Burns, Kiran T Thakur, Kimbell L Hetzler, Janell A Routh, Jennifer L Konopka-Anstadt, W Allan Nix, Rafal Tokarz, Thomas Briese, M Steven Oberste, and W Ian Lipkin mBio 2019 Aug (4) |
- Page last reviewed:Oct 1, 2020
- Page last updated:Mar 02, 2021
- Content source: